LytU-SH3b fusion protein as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.

LytU-SH3b fusion protein as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.

Methicillin-resistant Staphylococcus aureus (MRSA) is a difficult infectious agent worldwide. The ever rising antibiotic resistance has made the researchers to search for new anti-staphylococcal brokers. Autolysins are staphylococcal enzymes that lyse bacterial cell wall for cell division. Autolysins can be utilized as novel enzybiotics (enzymes have antibiotic results) for staphylococcal infections. LytU is a newly explored autolysin. […]